Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STREAM trial of Saireito for prevention of high-output syndrome after temporary ileostomy in rectal cancer
jRCTs051260196Recruiting
- Sponsor
- Tsumura & Co.
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of saireito in rectal cancer (2 arms), sponsored by Tsumura & Co. Primary endpoint: Incidence of high-output syndrome from postoperative day 1 through postoperative day 10. Started Oct 2026; status: recruiting.
02
Drugs
saireito
03
Conditions
rectal cancer
Beyond the preview
Go deeper on jRCTs051260196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051260196.